Calidi BiotherapeuticsCLDI
CLDI
$1.13
2.73%
Market Cap: $9.14M
About: Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.
Employees: 41
0
Funds holding %
of 6,710 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
3% more funds holding
Funds holding: 31 [Q1] → 32 (+1) [Q2]
3.54% less ownership
Funds ownership: 7.72% [Q1] → 4.18% (-3.54%) [Q2]
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
66% less capital invested
Capital invested by funds: $1.54M [Q1] → $523K (-$1.02M) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$10
785%
upside
Avg. target
$10
785%
upside
High target
$10
785%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
Ladenburg Thalmann Aydin Huseynov 0 / 0 met price target | 785%upside $10 | Buy Initiated | 27 Jun 2024 |